BRIEF—Perrigo names Uwe Röhrhoff as president and CEO

Following the retirement of John Hendrickson, Ireland-incorporated generic and OTC drugmaker Perrigo has appointed Uwe Röhrhoff as president and chief executive, effective January 15, 2018.

Mr Hendrickson, who joined Perrigo in 1989, became chief executive after Joe Papa left in April 2016 but announced his decision to retire in June 2017.

Most recently as CEO, Mr Röhrhoff has more than 25 years of experience with Gerresheimer AG, a leading global manufacturer of pharmaceutical packaging products and medical devices for storage, dosage and safe administration of drugs that generated approximately 1.4 billion euros ($1.68 billion)

Mr Röhrhoff serves as audit committee chairman on the board of Catalent, a global provider of drug delivery technology and development solutions for drugs, biologics and consumer health products. He is also deputy chairman of Klöckner & Co SE, one of the world's largest producer-independent steel and metal distributors. Mr Röhrhoff plans to step down from both boards. He earned a business administration degree from the University of Cologne.